MONTELUKAST SOD. IP

उत्पाद विवरण

Montelukast Sodium, as defined by the Indian Pharmacopoeia (IP), is a pharmaceutical compound categorized as a leukotriene receptor antagonist. It is primarily prescribed for the treatment of asthma and allergic rhinitis, conditions where it helps alleviate symptoms by blocking the action of leukotrienes, which are inflammatory molecules in the body.